These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26428246)

  • 21. In Vivo Red Blood Cells/Plasma Partition Coefficient of Treosulfan and Its Active Monoepoxide in Rats.
    Romański M; Zacharzewska A; Teżyk A; Główka FK
    Eur J Drug Metab Pharmacokinet; 2018 Oct; 43(5):565-571. PubMed ID: 29542019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical bioanalysis of treosulfan and its epoxides: The importance of collected blood processing for valid pharmacokinetic results.
    Romański M; Główka F
    J Pharm Biomed Anal; 2018 May; 153():199-203. PubMed ID: 29501039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytostatic conditioning in experimental allogeneic bone marrow transplantation: Busulfan causes less early gastrointestinal toxicity but Treosulfan results in improved immune reconstitution.
    Bouazzaoui A; Dickhöfer S; Kreuz M; Huber E; Holler E; Wolff D
    Immunopharmacol Immunotoxicol; 2014 Apr; 36(2):158-64. PubMed ID: 24588615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppressive effects of low-dose 5-fluorouracil, busulfan or treosulfan on the expansion of circulatory neutrophils and myeloid derived immunosuppressor cells in tumor-bearing mice.
    Abedi-Valugerdi M; Wolfsberger J; Pillai PR; Zheng W; Sadeghi B; Zhao Y; Hassan M
    Int Immunopharmacol; 2016 Nov; 40():41-49. PubMed ID: 27580414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA alkylation and interstrand cross-linking by treosulfan.
    Hartley JA; O'Hare CC; Baumgart J
    Br J Cancer; 1999 Jan; 79(2):264-6. PubMed ID: 9888467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose treosulfan in conditioning prior to hematopoietic stem cell transplantation.
    Główka FK; Romański M; Wachowiak J
    Expert Opin Investig Drugs; 2010 Oct; 19(10):1275-95. PubMed ID: 20836619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gonadal Function after Busulfan Compared with Treosulfan in Children and Adolescents Undergoing Allogeneic Hematopoietic Stem Cell Transplant.
    Faraci M; Diesch T; Labopin M; Dalissier A; Lankester A; Gennery A; Sundin M; Uckan-Cetinkaya D; Bierings M; Peters AMJ; Garwer M; Schulz A; Michel G; Giorgiani G; Gruhn B; Locatelli F; Giardino S; Uyttebroeck A; Rialland F; Itäla-Remes M; Dreger P; Shaw PJ; Bordon V; Schlegel PG; Mellgren K; Moraleda JM; Patrick K; Schneider P; Jubert C; Lawitschka A; Salooja N; Basak GW; Corbacioglu S; Duarte R; Bader P;
    Biol Blood Marrow Transplant; 2019 Sep; 25(9):1786-1791. PubMed ID: 31082473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of treosulfan in pediatric patients undergoing hematopoietic stem cell transplantation.
    Ten Brink MH; Ackaert O; Zwaveling J; Bredius RG; Smiers FJ; den Hartigh J; Lankester AC; Guchelaar HJ
    Ther Drug Monit; 2014 Aug; 36(4):465-72. PubMed ID: 24487253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Central nervous system distribution kinetics of indinavir in rats.
    Hamidi M
    J Pharm Pharmacol; 2007 Aug; 59(8):1077-85. PubMed ID: 17725849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of high-dose i.v. treosulfan in children undergoing treosulfan-based preparative regimen for allogeneic haematopoietic SCT.
    Główka FK; Karaźniewicz-Łada M; Grund G; Wróbel T; Wachowiak J
    Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S67-70. PubMed ID: 18978748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treosulfan-thiotepa-fludarabine-based conditioning regimen for allogeneic transplantation in patients with thalassemia major: a single-center experience from north India.
    Choudhary D; Sharma SK; Gupta N; Kharya G; Pavecha P; Handoo A; Setia R; Katewa S
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):492-5. PubMed ID: 23160007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central nervous system penetration of antiretroviral drugs: pharmacokinetic, pharmacodynamic and pharmacogenomic considerations.
    Decloedt EH; Rosenkranz B; Maartens G; Joska J
    Clin Pharmacokinet; 2015 Jun; 54(6):581-98. PubMed ID: 25777740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Personalized busulfan and treosulfan conditioning for pediatric stem cell transplantation: the role of pharmacogenetics and pharmacokinetics.
    ten Brink MH; Zwaveling J; Swen JJ; Bredius RG; Lankester AC; Guchelaar HJ
    Drug Discov Today; 2014 Oct; 19(10):1572-86. PubMed ID: 24747172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of treosulfan in plasma and urine by HPLC with refractometric detection; pharmacokinetic studies in children undergoing myeloablative treatment prior to haematopoietic stem cell transplantation.
    Główka FK; Łada MK; Grund G; Wachowiak J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):569-74. PubMed ID: 17210272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central nervous system penetration for small molecule therapeutic agents does not increase in multiple sclerosis- and Alzheimer's disease-related animal models despite reported blood-brain barrier disruption.
    Cheng Z; Zhang J; Liu H; Li Y; Zhao Y; Yang E
    Drug Metab Dispos; 2010 Aug; 38(8):1355-61. PubMed ID: 20427691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies.
    Scheulen ME; Hilger RA; Oberhoff C; Casper J; Freund M; Josten KM; Bornhäuser M; Ehninger G; Berdel WE; Baumgart J; Harstrick A; Bojko P; Wolf HH; Schindler AE; Seeber S
    Clin Cancer Res; 2000 Nov; 6(11):4209-16. PubMed ID: 11106234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic considerations in the treatment of CNS tumours.
    Motl S; Zhuang Y; Waters CM; Stewart CF
    Clin Pharmacokinet; 2006; 45(9):871-903. PubMed ID: 16928151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow-up of children conditioned with Treosulfan: German and Austrian experience.
    Beier R; Schulz A; Hönig M; Eyrich M; Schlegel PG; Holter W; Stachel KD; Ehlert K; Greil J; Nürnberger W; Wössmann W; Bader P; Urban C; Müller I; Suttorp M; Sauer M; Gruhn B; Meisel R; Zimmermann M; Sykora KW
    Bone Marrow Transplant; 2013 Apr; 48(4):491-501. PubMed ID: 23085832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetic and Mechanistic Study of the pH-Dependent Activation (Epoxidation) of Prodrug Treosulfan Including the Reaction Inhibition in a Borate Buffer.
    Romański M; Ratajczak W; Główka F
    J Pharm Sci; 2017 Jul; 106(7):1917-1922. PubMed ID: 28342883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. European Society for Blood and Marrow Transplantation Analysis of Treosulfan Conditioning Before Hematopoietic Stem Cell Transplantation in Children and Adolescents With Hematological Malignancies.
    Boztug H; Sykora KW; Slatter M; Zecca M; Veys P; Lankester A; Cant A; Skinner R; Wachowiak J; Glogova E; Pötschger U; Peters C
    Pediatr Blood Cancer; 2016 Jan; 63(1):139-48. PubMed ID: 26398915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.